This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: The Innovative Contributions of Karin Bressler
Introduction
Karin Bressler is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of withdrawal symptoms associated with drug abuse. Her innovative work has led to the development of a unique pharmaceutical agent that addresses a critical need in addiction treatment.
Latest Patents
Karin Bressler holds 1 patent for her invention titled "Pharmaceutical agent for treatment of withdrawal symptoms." This patent describes the use of non-NMDA receptor antagonists, such as quisqualate or kainate antagonists, and their physiologically compatible salts for treating withdrawal symptoms. Additionally, it explores the combination of these new pharmaceutical agents with NMDA antagonists, showcasing her innovative approach to addressing addiction.
Career Highlights
Karin Bressler is associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. Her work at Schering has allowed her to focus on developing solutions that can significantly improve the lives of individuals struggling with addiction. Her dedication to research and innovation has positioned her as a key figure in her field.
Collaborations
Throughout her career, Karin has collaborated with esteemed colleagues, including Lechoslaw Turski and David N. Stephens. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Karin Bressler's contributions to the pharmaceutical industry highlight her commitment to innovation and improving treatment options for addiction. Her work exemplifies the impact that dedicated inventors can have on society.